14 JUL 2023 | EU | EMA confirms acceptance of Intas’ MAA for its ustekinemab (Stelara®) biosimilar Intas...
BioBlast w/e 14 Jul 23
read more
Home / News / Pearce IP Blog
ALL BLOGS BY
Kate Legge
Kate is an experienced IP and patent lawyer, providing IP leadership for pharmaceutical product development and commercialisation in global markets – from initial scoping through to post-launch. She has developed and implemented global IP strategies over more than 15 years at multi-national pharmaceutical companies. She is an Australian qualified and registered legal practitioner, and has a Master’s degree in IP Law and a BSc in biochemistry.
See Kate's full profile
Cannabidiol PBS listing expanded: Chiesi secures second PBS reimbursed indication for Epidyolex®
The PBS listing for Chiesi’s Epidyolex®, an oral cannabidiol, was expanded on 1 June 2023 to include treatment of...
Threats of infringement unjustified after swimming pool door hinge patents revoked
TCT Group Pty Ltd v Polaris IP Pty Ltd [2022] FCA 1189Date:Court:Judge:14 December 2022Federal Court of...
Fall from Grace: Patent Office allows extension of time for claim to grace period but patent still found invalid
Generic Partners Pty Ltd v Neurim Pharmaceuticals Ltd [2022] APO 2 Generic Partners Pty Ltd v Neurim Pharmaceuticals...
Account of profits/damages as complex as validity/infringement
Aristocrat Technologies Australia Pty Limited v Konami Australia Pty Limited (No 3) [2022] FCA 1373...
Long-running mining systems dispute reaches the merits phase – Globaltech still infringing
Australian Mud Company Pty Ltd v Globaltech Corporation Pty Ltd & Ors (No 3) [2022] FCA 1189 ...
Establishing infringement of representative batches may be insufficient to establish liability
Pharmacia LLC v Juno Pharmaceuticals Pty Ltd [2022] FCA 92Pharmacia LLC v Juno Pharmaceuticals Pty Ltd (No 2) [2022]...
Amgen’s five PCSK9 mAb patents upheld in opposition
Sanofi v Amgen Inc. [2022] APO 67Date:Venue:Delegate:26 September 2022Australian Patent OfficeSophina...
PiPCast™ | Expedited Patent Prosecution in Australia and New Zealand
PiPCast™ | Expedited Patent Prosecution in Australia and New Zealand
Jayne Jagot appointed to Australia’s High Court bench – a new era for diversity and for patent law
The Australian High Court will have an experienced intellectual property judge on its bench, with the appointment of...
PiPCast™ | Biosimilars – strategies for AU market entry
In this PiPCast®, Naomi Pearce and Kate Legge walk through the key IP strategies biosimilars companies are using to enable market entry globally, and canvas biosimilar litigation in Australian courts. They also discuss recent litigation settlement activity and lessons learnt.
PiPCast™ | The implications of recent DABUS Federal Court decisions for life sciences companies
In this PiPCast™, Kate Legge discusses whether a patent inventor must be human or can include artificial intelligence systems in Australia, and look to the future legal developments in this space.
High Court has a bet each way on electronic gaming machine patent
Aristocrat Technologies Australia Pty Ltd v Commissioner of Patents [2022] HCA 29Date:Court:Judges:17 June 2022High...
High Court has a bet each way on electronic gaming machine patent
Even the High Court of Australia could not come to a majority decision on the thorny question of the patentability of...
The Rise and Rise of CAR-T cell therapy and the Future of Patent Disputes in Australia
First published by WIPR on 22 June 2022
Chimeric Antigen Receptor (CAR)-T cell therapy is a pioneering technology that is successfully changing the way we...
Full Court dismisses Boehringer appeal on obviousness of veterinary injectable formulation
The Full Court’s decision in Boehringer Ingelheim Animal Health USA Inc., v Intervet International B.V. [2022] FCAFC...